BREAST CANCER FEMALE
Clinical trials for BREAST CANCER FEMALE explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER FEMALE trials appear
Sign up with your email to follow new studies for BREAST CANCER FEMALE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer combo trial halted early: what happened?
Disease control TerminatedThis early-stage trial tested a new drug, azenosertib, combined with two standard cancer drugs (carboplatin and pembrolizumab) in people with metastatic triple-negative breast cancer. The goal was to find a safe dose and see if the combination shrank tumors. Only 7 people took pa…
Matched conditions: BREAST CANCER FEMALE
Phase: PHASE1 • Sponsor: Filipa Lynce, MD • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Botswana study investigates tamoxifen adherence in breast cancer patients
Knowledge-focused TerminatedThis study looked at why some women with breast cancer in Botswana stop taking tamoxifen, a key hormone therapy. Researchers focused on side effects, quality of life, and HIV status. The study was terminated early and only enrolled 10 participants, so findings are limited.
Matched conditions: BREAST CANCER FEMALE
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC